Biorem Inc. BRM
TSXV · Canada · Producer Manufacturing
CAD 3.39+0.10 (+3.04%)
Market open· · CAD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · CAD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
BIOREM Inc. (TSXV: BRM) ("BIOREM" or "the Company") today announced results for the three month period ended June 30, 2026. BIOREM's complete 2026 second quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
BIOREM Inc. (TSXV: BRM) ("BIOREM" or "the Company") today announced results for the three month period ended March 31, 2026. BIOREM's complete 2026 first quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
BioRem Inc.'s ( CVE:BRM ) strong earnings report was rewarded with a positive stock price move. We did some digging and...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.